NMDA antagonist acting at the polyamine site; Neuroprotective agent; α-Adrenergic central and peripheral vasodilator; α2 adrenergic receptor ligand

Used experimentally as a beta blocker and clinically as a strong vasodilator with the noted side effects of reduced systolic, diastolic and mean arterial pressure.

Yoda1 analogue, antagonizing Yoda1-evoked activation of Piezo1 and aortic relaxation.

Novel subtilisin kexin isozyme-1/site-1 (SKI-1/S1P) protease inhibitor

The only known preferential antagonist for P2Y(AC) receptor; this is the platelet ADP receptor that is coupled to adenyl cyclase and is also referred to as the P2Y ADP receptor.